Merck & Co., Inc. (MRK)
106.62
-0.16
(-0.15%)
USD |
NYSE |
Dec 29, 16:00
106.47
-0.15
(-0.14%)
Pre-Market: 06:02
Merck Research and Development Expense (TTM): 14.26B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Biogen, Inc. | 1.524B |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Cidara Therapeutics, Inc. | 131.82M |
| Moderna, Inc. | 3.271B |